Results 11 to 20 of about 440,067 (322)

PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer

open access: yesFrontiers in Oncology, 2022
BackgroundThe aim of this study was to evaluate the clinical usefulness of radiomics signature-derived 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography–computed tomography (PET-CT) for the early prediction of neoadjuvant chemotherapy (NAC ...
Liping Yang   +10 more
doaj   +1 more source

A heterogeneous phantom study for investigating the stability of PET images radiomic features with varying reconstruction settings

open access: yesFrontiers in Nuclear Medicine, 2023
The purpose of this work was to assess the capability of radiomic features in distinguishing PET image regions with different uptake patterns. Furthermore, we assessed the stability of PET radiomic features with varying image reconstruction settings.
Emad Alsyed   +5 more
doaj   +1 more source

Searching for annihilation radiation from SN 1006 with SPI on INTEGRAL [PDF]

open access: yes, 2006
Historical Type Ia supernovae are a leading candidate for the source of positrons observed through their diffuse annihilation emission in the Galaxy.
E. Kalemci   +4 more
core   +2 more sources

Habitat Imaging-Based 18F-FDG PET/CT Radiomics for the Preoperative Discrimination of Non-small Cell Lung Cancer and Benign Inflammatory Diseases

open access: yesFrontiers in Oncology, 2021
PurposeTo propose and evaluate habitat imaging-based 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) radiomics for preoperatively discriminating non-small cell lung cancer (NSCLC) and benign inflammatory ...
Ling Chen   +5 more
doaj   +1 more source

Positron Emission Tomography

open access: yes, 2016
Positron emission tomography (PET) is a minimally invasive imaging procedure with a wide range of clinical and research applications. PET allows for the three-dimensional mapping of administered positron-emitting radiopharmaceuticals such as (18)F-fluorodeoxyglucose (for imaging glucose metabolism).
Katherine Lameka   +2 more
  +10 more sources

Positron emission tomography

open access: yesMethods, 2002
Positron Emission Tomography (PET) is a method for determining biochemical and physiological processes in vivo in a quantitative way by using radiopharmaceuticals labelled with positron emitting radionuclides as C-11, N-13, O-15 and F-18 and by measuring the annihilation radiation using a coincidence technique. This includes also the measurement of the
Aren van Waarde, Anne M. J. Paans
openaire   +4 more sources

Positron-emission tomography [PDF]

open access: yesIEEE Signal Processing Magazine, 1997
We review positron-emission tomography (PET), which has inherent advantages that avoid the shortcomings of other nuclear medicine imaging methods. PET image reconstruction methods with origins in signal and image processing are discussed, including the potential problems of these methods. A summary of statistical image reconstruction methods, which can
Ollinger, John M., Fessler, Jeffrey A.
openaire   +3 more sources

Detectors in positron emission tomography

open access: yesZeitschrift für Medizinische Physik, 2023
Positron emission tomography is a highly sensitive molecular imaging modality, based on the coincident detection of annihilation photons after positron decay. The most used detector is based on dense, fast, and luminous scintillators read out by light sensors. This review covers the various detector concepts for clinical and preclinical systems.
Zatcepin, Artem, Ziegler, Sibylle I
openaire   +3 more sources

PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging

open access: yesFrontiers in Neuroscience, 2022
The development of novel PET imaging agents for synaptic vesicle glycoprotein 2A (SV2A) allowed for the in vivo detection of synaptic density changes, which are correlated with the progression and severity of a variety of neuropsychiatric diseases. While
Takuya Toyonaga   +6 more
doaj   +1 more source

Reliability of gradient-based segmentation for measuring metabolic parameters influenced by uptake time on 18F-PSMA-1007 PET/CT for prostate cancer

open access: yesFrontiers in Oncology, 2022
PurposeTo determine an optimal setting for functional contouring and quantification of prostate cancer lesions with minimal variation by evaluating metabolic parameters on 18F-PSMA-1007 PET/CT measured by threshold-based and gradient-based methods under ...
Yu Ching Lau   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy